Selective beta2-receptor agonists for the treatment of asthma--therapeutic breakthrough or advertising ploy? A commentary.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007528:Isoetharine / Q000494:pharmacology / Q000627:therapeutic use; D007545:Isoproterenol / Q000494:pharmacology / Q000627:therapeutic use; D009921:Metaproterenol / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D013726:Terbutaline / Q000494:pharmacology / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D009921:Metaproterenol; D007545:Isoproterenol; D013726:Terbutaline; D007528:Isoetharine